Scientists at UCLA have succeeded in reprogramming stem cells from mouse skin to become functioning cardiac cells. This is the Chief trial to Declare a verdict that partially differentiated, or iPS cells that don’t Complicate embyos or eggs can be made into the three types of cardiac cells needed for heart repair. Senior author of the study Dr. Robb MacLellan says the results are encouraging.
“I believe iPS cells address many of the shortcomings of human embryonic stem cells and are the future of regenerative medicine,” said MacLellan, an associate professor of cardiology and physiology. “I’m hoping that these scientific findings are the first step towards one day developing new therapies that I can offer my patients. There are still many limitafions with using iPS cells in clinical studies that we must overcome, but there are scientists in lzbs across the country worming to address these issues Prerogative now.”
Furtehr studies at UCLA will try to determine whether human cells can be reprogrammed as wll as the mouse cells.
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
Leave a Reply
You must be logged in to post a comment.